155 related articles for article (PubMed ID: 10227764)
1. Plasmapheresis for removal of myeloperoxidase antineutrophil cytoplasmic antibodies: a case report.
Yorioka N; Taniguchi Y; Amimoto D; Katsutani M; Kumagai J; Yamakido M
Ther Apher; 1998 Nov; 2(4):314-6. PubMed ID: 10227764
[TBL] [Abstract][Full Text] [Related]
2. [An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis].
Takeda T; Takeda T; Naiki Y; Yonekawa S; Sakaguchi M; Iwamoto I; Tanaka H; Hasegawa H; Imada A; Kanamaru A; Hiruma S; Maekura S; Hashimoto S; Yamazumi T
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):591-6. PubMed ID: 9893458
[TBL] [Abstract][Full Text] [Related]
3. [A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents].
Fujimoto T; Kimura A; Ameno M; Shiiki H; Dohi K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):172-7. PubMed ID: 9134836
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
[TBL] [Abstract][Full Text] [Related]
5. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy.
Taniguchi Y; Yorioka N; Kumagai J; Ito T; Yamakido M; Taguchi T
Clin Nephrol; 1999 Oct; 52(4):253-5. PubMed ID: 10543328
[TBL] [Abstract][Full Text] [Related]
7. Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis.
Yorioka N; Taniguchi Y; Amimoto D; Miyata H; Yamakido M; Taguchi T
Am J Nephrol; 1999; 19(4):527-9. PubMed ID: 10460948
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies -- related scleroderma renal crisis treated with double-filtration plasmapheresis.
Omote A; Muramatsu M; Sugimoto Y; Hosono S; Murakami R; Tanaka H; Watanabe Y; Sano H; Kato K
Intern Med; 1997 Jul; 36(7):508-13. PubMed ID: 9240503
[TBL] [Abstract][Full Text] [Related]
9. Crescentic glomerulonephritis with positive antineutrophil cytoplasmic autoantibody specific for myeloperoxidase associated with autoimmune hemolytic anemia and thrombocytopenic purpura.
Ohhashi J; Miyamoto M; Ishikawa S; Hashizume Y; Nishido T; Matsuyama K; Morino K; Miyazaki Y
Intern Med; 2000 Aug; 39(8):650-4. PubMed ID: 10939540
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis associated with rheumatoid arthritis: An unusual case report.
Hsieh HS; Chang CF; Yang AH; Kuo HL; Yang WC; Lin CC
Nephrology (Carlton); 2003 Oct; 8(5):243-7. PubMed ID: 15012711
[TBL] [Abstract][Full Text] [Related]
11. Effect of plasmapheresis as initial monotherapy in a case of anti-neutrophil cytoplasmic autoantibody positive crescentic glomerulonephritis.
Akimoto T; Ando Y; Ito C; Muto S; Kusano E; Asano Y
ASAIO J; 1999; 45(5):509-13. PubMed ID: 10503634
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
[TBL] [Abstract][Full Text] [Related]
14. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
[TBL] [Abstract][Full Text] [Related]
15. Younger onset myeloperoxidase-specific antineutrophil cytoplasmic antibody- (MPO-ANCA) related glomerulonephritis accompanied with nephrotic syndrome.
Kaneko Y; Kamijo Y; Kobayashi N; Higuchi M; Ehara T; Hora K; Shigematsu H; Kiyosawa K
Clin Nephrol; 2003 Oct; 60(4):275-8. PubMed ID: 14579943
[TBL] [Abstract][Full Text] [Related]
16. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].
Mizutani A; Tanaka I; Katayama M; Oshima H; Komatsu Y; Asano S; Kato K; Matsumura H; Ishii K; Miyama H; Nagai T; Kato K; Fukaya S; Yoshida S; Hasegawa M; Kawashima S; Torikai K
Ryumachi; 2000 Oct; 40(5):828-32. PubMed ID: 11215162
[TBL] [Abstract][Full Text] [Related]
17. [A case of myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA)-related glomerulonephritis associated with Cogan's syndrome].
Suzuki M; Arimura Y; Minoshima S; Fukuoka K; Miyake N; Ishizuka S; Soejima A; Nakabayashi K; Kitamoto K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1996 Sep; 38(9):423-7. PubMed ID: 8913096
[TBL] [Abstract][Full Text] [Related]
18. Plasmapheresis in treatment of acute oligoanuria in crescentic glomerulonephritis.
Grcevska L; Polenaković M; Stojkovski L; Polenaković H
Artif Organs; 1998 Oct; 22(10):827-30. PubMed ID: 9790079
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase Antineutrophil Cytoplasmic Antibody (MPO-ANCA) Associated Crescentic and Necrotizing Glomerulonephritis (GN) with Membranoproliferative GN Features.
Koda R; Nagahori K; Kitazawa A; Imanishi Y; Yoshino A; Kawamoto S; Ueda Y; Takeda T
Intern Med; 2016; 55(15):2043-8. PubMed ID: 27477412
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody.
Srivastava A; Rao GK; Segal PE; Shah M; Geetha D
Clin Rheumatol; 2013 Sep; 32(9):1317-22. PubMed ID: 23624587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
